In this case study with Foundation Fighting Blindness, the world’s leading private funder of retinal disease research, we share how our genetics experts addressed some key challenges faced by the Foundation:
- Difficult to identify trial candidates
- Scarity of genetic testing data
- Limited access to genetic specialists
The program impacted care for greater than 30% of clinical trial participants.